Azurity Pharmaceuticals's latest lobbying report covers Q2 2026, at $30K. Its first report covers Q2 2026; the issues it reports most are Health Issues.

Azurity Pharmaceuticals

Latest quarter: No record; Q3 2026 · 0 reports
Last 12 months: $30K; Last 2 quarters
vs last quarter: −100.0%; Q3 2026 against the quarter before
First report: Q2 2026; The first quarter a report named it

Lobbying by quarter

Azurity Pharmaceuticals lobbying by quarter
Quarter	Amount	Reports
Q2 2026	$30K	1
Q3 2026	$0	0

By issue

Health issues$30K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

HOUSE OF REPRESENTATIVES1 reports
SENATE1 reports

Firms it paid

Firm
The KPM Group DC	$30K	1 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

	Filed by		Issues
07/20for Q2	The KPM Group DC	$30K	Health issues
07/19for Q2	The KPM Group DC	Under $5,000	Health issues